Skip to main content

PMV Pharmaceuticals, Inc.

PMVP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001699382

No open-market purchases or sales by PMV Pharmaceuticals, Inc. insiders were filed in the last 90 days; 64 institutions reported holding it in 13F filings for Q2 2026, worth $45.9M in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding PMV Pharmaceuticals, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of PMVP: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders113106−7
Shares51.5M51.8M+271.8K (+0.5%)
Value$245.7M$324.0M+$78.3M (+31.8%)

New holders (16)

Institutions that held PMV Pharmaceuticals, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to PMVP in Q2 2023
InstitutionSharesValue% of portfolio
Bank of Montreal698,184$4.44M0.00%
Octagon Capital Advisors LP470,000$2.94M0.41%
Ghost Tree Capital, LLC280,981$1.76M0.63%
Tri Locum Partners LP158,413$991.7K0.37%
Gsa Capital Partners LLP114,604$717.0K0.07%
Bridgeway Capital Management, LLC95,000$594.7K0.01%
Mesirow Financial Investment Management, Inc.34,748$217.5K0.92%
Prudential Financial Inc33,360$208.8K0.00%
Denali Advisors LLC30,500$190.9K0.07%
XTX Topco Ltd27,225$170.4K0.03%
Belvedere Trading LLC24,411$152.8K0.05%
AQR Capital Management LLC23,667$148.2K0.00%
American Century Companies Inc20,665$129.4K0.00%
State Board of Administration of Florida Retirement System10,944$68.5K0.00%
Simplex Trading, LLC10,692$66.0K0.00%
Nisa Investment Advisors, LLC3,485$21.8K0.00%

Sold out (23)

Institutions that held PMV Pharmaceuticals, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.